Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, says the U.S. is “in for a difficult journey” as Covid’s new changes roll out across the country.
“Being more mobile means more Americans will be infected, so even though we’ve seen a small reduction in the number of new cases … expect it now, it’s going back because of these new variables, “Hotez said in an interview Thursday night on” The News with Shepard Smith. “” More and more people are going to catch the disease, start recovering from hospital systems again, and the death rate may start to rise, both from a combination of new cases in the UK. and also may have slightly higher mortality rates than the direct part depending on the nature of the change. “
Health officials in South Carolina have confirmed two cases of Covid South Africa’s dangerous, portable brand. Officials said the cases do not appear to be linked and have not been linked to any recent travel. Dr Zeke Emanuel, a member of President Joe Biden’s Covid Advisory Board, said that is why South Africa’s pressure is so worrying.
“This is worrying because these two have no travel evidence, so it means that the South African variety, which is more worrying than even the British variant, is around and in the community,” said Emanuel.
Hotez told guest Shep Smith that the new rays are even more troublesome because “we hadn’t been watching.”
“We’ve been so strong at performing in genomic order, and that’s how we build the UK, South Africa, Brazilian variables, so we know they’re in Carolina South, but they could be elsewhere, “said the dean of Nationals. School of Tropical Medicine at Baylor College of Medicine.
The Centers for Disease Control and Prevention has warned that the UK variant, also known as B117, could dominate the U.S. by spring. Hotez said that vaccinating people at a faster rate was the best way to protect the population.
“The bottom line is that we need to find a way to vaccinate the American people faster than conventional predictions,” Hotez said. “One, to reduce hospitalization and death, but also to get over those variables. If we can vaccinate three-quarters of the American population, we could prevent transmission and prevent some of those variables. These new ones have the upper hand. “